6th Symposium TECAM – abstracts

OPENING SPECIAL LECTURES
Rebuilding the heart in Darwin’s year José Manuel Sánchez Ron ico_video ico_doc
Gene and stem cell therapy for cardiovascular diseases. Historical perspective and challenges for the future. Valentín Fuster ico_video ico_doc
New consensus on stem cell therapy for heart repair. John Martin ico_video ico_zip
WHAT’S NEW?
On embryonic and embryonic-like cells? André Terzic   ico_zip
On classical and new adult cells? Mark S. Penn ico_video ico_doc
On heart tissue reengineering? Juan Carlos Chachques ico_video ico_doc
On delivering and navigation? Emerson Perin    
On clinical trials? Kai C. Wollert ico_video ico_doc
On imaging? Jonathan Hill    
On new organizational models for optimal cell processing and application? Robert Simari ico_video ico_doc
On regulatory? Natividad Calvente    
SPECIAL THEMED SESSION: “NEW HEARTS FOR OLD AND NEW NEEDS”
Cardiac replacement for end-stage heart disease: need, demand, supply and dreams. Magdi Yacoub ico_video ico_doc
Bridge? Destination? Both? New paradigms in mechanical heart replacement. O. Howard Frazier    
Heart replacement in the age of stem cell therapy and biosensors technology. What we know and what we can expect. Philippe Menasché ico_video ico_doc
Xenotransplant. Still a hope? Emanuelle Cozzi ico_video ico_doc
Stem cell-based heart replacement: the Taylor Heart. Doris Taylor ico_video ico_zip
BEST POSTERS PRESENTATION
Myocardial infarction repair with human stemness factors induced iPS Nelson TJ ico_video ico_zip
Transplantation of mesenchymal stem cells exerts a greater long-term effect than BM-MNC in chronic myocardial infarction in RAT Manuel Mª Mazo Vega ico_video ico_doc
Autologous BONe Marrow Mononucleated Cell Infusion for Acute Myocardial Infarction in Patients with Severe Left Ventricular Dysfunction P. Lemarchand ico_video ico_doc
CONTROVERSIES
Stem cell therapy treatment in AMI after meta-analyses results? – PRO Andreas Zeiher ico_video ico_doc
Stem cell therapy treatment in AMI after meta-analyses results? – CONTRA Bernard Gersh ico_video ico_doc
Is it time to use allogenic stem cells? – PRO Mark S. Penn ico_video ico_doc
Is it time to use allogenic stem cells? – CONTRA Dominique Charron ico_video ico_doc
CLOSING SESSION: “NEXT STEPS IN HEART REPLACEMENT”
My fundamental view. Juan Carlos Izpisúa    
My preclinical view. Doris Taylor    
My translational view. Philippe Menasché ico_video ico_doc
My clinical view. William Wijns ico_video ico_doc
My global view. Magdi Yacoub ico_video ico_doc
ADJOURN Francisco Fernández-Avilés ico_video ico_doc